Author

A. MASID

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. BHAUMIK· 2 shared O. DAS· 2 shared A. BANERJEE· 1 shared A. DUTTA· 1 shared A. GAUTAM· 1 shared A. GHOSH· 1 shared D. ROY· 1 shared M. CHAKRABORTY· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. BHAUMIK

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BUTYRATE AMELIORATES INFLAMMATION IN COLON BIOPSY SAMPLES OF IBD PATIENTS AND EXPERIMENTAL COLITIS IN MICE INVOLVING RNA BINDING PROTEIN, AUF1-IL-27 AXIS AND ACCELERATING B1a TO B10 POLARIZATION

A. MASID, O. DAS, D. ROY, A. DUTTA, S. SIKDAR, A. GHOSH, A. BANERJEE, U. GHOSH, S. A. CHOWDHURY, S. MAJUMDER, M. YAHYA, S. SINHA, M. BHAUMIK

This paper shows butyrate enhances B10 cell generation via the AUF1-IL-27 axis in IBD patients and mice, reducing inflammation.

bioRxiv · May 24, 2024 · PreprintImmunology

Prenatal arsenic exposure stymies gut butyrate production and enhances gut permeability in post natal life even in absence of arsenic deftly through miR122-Occludin pathway.

M. CHAKRABORTY, A. GAUTAM, O. DAS, A. MASID, M. BHAUMIK

This study shows prenatal arsenic exposure reduces gut butyrate production and increases permeability in mice, effects reversed by butyrate supplementation through miR122-Occludin pathway modulation.

bioRxiv · Jun 13, 2022Pharmacology & Toxicology